HPV integration detection in CaSki and SiHa using detection of integrated papillomavirus sequences and restriction-site PCR

Journal of Virological Methods

Volumn 206, Issue , 2014, Pages 51-54

  Raybould, Rachel ^a   Fiander, Alison ^a   Wilkinson, Gavin W G ^a   Hibbitts, Sam ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

CaSki; Cervical cancer; Human papillomavirus; SiHa; Viral integration

Indexed keywords

GENOMIC DNA;

AMPLICON; ANALYTICAL PARAMETERS; ARTICLE; CASKI CELL LINE; CELL LINE; DETECTION OF INTEGRATED PAPILLOMAVIRUS SEQUENCE; DIGESTION TIME; DNA SEQUENCE; GENE DOSAGE; GENE REARRANGEMENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; INCUBATION TIME; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION SITE POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SIHA CELL LINE; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME; GENETICS; PAPILLOMAVIRIDAE; PHYSIOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; HUMANS; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; VIRUS INTEGRATION;

EID: 84902336625     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2014.05.017     Document Type: Article

References (18)

1. Baker C.C., Phelps W.C., Lindgren V., Braun M.J., Gonda M.A., Howley P.M. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 1987, 61:962-971.
2. Durst M., Dzarlieva-Petrusevska R.T., Boukamp P., Fusenig N.E., Gissmann L. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene 1987, 1:251-256.
3. Ferber M.J., Montoya D.P., Yu C., Aderca I., McGee A., Thorland E.C., Nagorney D.M., Gostout B.S., Burgart L.J., Boix L., Bruix J., McMahon B.J., Cheung T.H., Chung T.K., Wong Y.F., Smith D.I., Roberts L.R. Integrations of the hepatitis B virus (HBV) and human papillomavirus (HPV) into the human telomerase reverse transcriptase (hTERT) gene in liver and cervical cancers. Oncogene 2003, 22:3813-3820.
4. Ferber M.J., Thorland E.C., Brink A.A., Rapp A.K., Phillips L.A., McGovern R., Gostout B.S., Cheung T.H., Chung T.K., Fu W.Y., Smith D.I. Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Oncogene 2003, 22:7233-7242.
5. Kadaja M., Silla T., Ustav E., Ustav M. Papillomavirus DNA replication - from initiation to genomic instability. Virology 2009, 384:360-368.
6. Klaes R., Woerner S.M., Ridder R., Wentzensen N., Duerst M., Schneider A., Lotz B., Melsheimer P., von Knebel Doeberitz M. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res. 1999, 59:6132-6136.
7. Li H., Yang Y., Zhang R., Cai Y., Yang X., Wang Z., Li Y., Cheng X., Ye X., Xiang Y., Zhu B. Preferential sites for the integration and disruption of human papillomavirus 16 in cervical lesions. J. Clin. Virol. 2013.
8. Luft F., Klaes R., Nees M., Durst M., Heilmann V., Melsheimer P., von Knebel Doeberitz M. Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells. Int. J. Cancer 2001, 92:9-17.
9. Matovina M., Sabol I., Grubisic G., Gasperov N.M., Grce M. Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions. Gynecol. Oncol. 2009, 113:120-127.
10. Meissner J.D. Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. J. Gen. Virol. 1999, 80(Pt 7):1725-1733.
11. Mincheva A., Gissmann L., zur Hausen H. Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization. Med. Microbiol. Immunol. 1987, 176:245-256.
12. Peter M., Stransky N., Couturier J., Hupe P., Barillot E., de Cremoux P., Cottu P., Radvanyi F., Sastre-Garau X. Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma. J. Pathol. 2010, 221:320-330.
13. Sarkar G., Turner R.T., Bolander M.E. Restriction-site PCR: a direct method of unknown sequence retrieval adjacent to a known locus by using universal primers. PCR Methods Appl. 1993, 2:318-322.
14. Thorland E.C., Myers S.L., Gostout B.S., Smith D.I. Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene 2003, 22:1225-1237.
15. Thorland E.C., Myers S.L., Persing D.H., Sarkar G., McGovern R.M., Gostout B.S., Smith D.I. Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. Cancer Res. 2000, 60:5916-5921.
16. Van Tine B.A., Kappes J.C., Banerjee N.S., Knops J., Lai L., Steenbergen R.D., Meijer C.L., Snijders P.J., Chatis P., Broker T.R., Moen P.T., Chow L.T. Clonal selection for transcriptionally active viral oncogenes during progression to cancer. J. Virol. 2004, 78:11172-11186.
17. Yee C., Krishnan-Hewlett I., Baker C.C., Schlegel R., Howley P.M. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am. J. Pathol. 1985, 119:361-366.
18. Ziegert C., Wentzensen N., Vinokurova S., Kisseljov F., Einenkel J., Hoeckel M., von Knebel Doeberitz M. A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques. Oncogene 2003, 22:3977-3984.